| 000 | 00000nam##2200000za#4500 |
| 001 | 9.687810 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624231138 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2005||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a0-662-41741-0 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-2/2005E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 10|aBudget impact analysis guidelines : |h[electronic resource]|bneeds assessment / |cPrepared by the Patented Medicine Review Board (PMPRB) under the provisions and conditions of the National Prescription Drug Utilization Information System (NPDUIS). |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |c[2005]. |
|---|
| 300 | |a58p.|bfigs., references, tables |
|---|
| 500 | |a"Analytical Study Series" Catalogue number and ISBN for the print version have been incorrectly copied in the PDF edition. |
|---|
| 590 | |a10-01-Supp|b2010-04-07 |
|---|
| 690 | 07|aPrescription drugs|2gcpds |
|---|
| 690 | 07|aHealth insurance|2gcpds |
|---|
| 775 | 08|tLignes directrices portant sur l'incidence du prix d'un médicament sur les budgets des régimes d'assurance médicaments : |w(CaOODSP)9.632249 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s4981 KB|uhttps://publications.gc.ca/collections/collection_2008/hc-sc/H82-2-2005E.pdf |
|---|